Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.15) by 26.67 percent. This is a 8.33 percent increase over losses of $(0.12) per share from the same period last year.
Gentex Corp Believes That Revenue Remains Difficult To Forecast For Remainder Of Year And Beyond; Says Co Has Been Likewise Affected By Industry-Wide Parts Shortages And Global Supply Constraints And Labor Shortages, As Well As UAW Strikes
- SEC Form 10 Filing
Automotive revenues represent approximately 97% - 99% of the Company's total revenue, consisting of interior and exterior electrochromic automatic-dimming rearview mirrors and automotive electronics.
